✦ LIBER ✦

Ablative procedures in patients with metastatic breast carcinoma

✍ Scribed by Samuel A. Wells Jr; Richard J. Santen

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 337 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840201)53:3+<762::aid-cncr2820531326>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fadrozole hydrochloride in postmenopausa

Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma

✍ Antonius A. Miller; Allan Lipton; I. Craig Henderson; Rudolph Navari; Mary T. Mu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 1 views

## BACKGROUND. Fadrozole hydrochloride (CGS-16949A) belongs to the class of aromatase inhibitors that lowers circulating estrogen levels by inhibiting the conversion of androgens to estrogens, thereby causing tumor regression in patients with breast carcinoma. METHODS. This was a prospective, ran

Predictors of skeletal complications in

Predictors of skeletal complications in patients with metastatic breast carcinoma

✍ Susan M. Domchek; Jerry Younger; Dianne M. Finkelstein; Michael V. Seiden 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Background: The high rate of incidence of skeletal complications in women with metastatic breast carcinoma appears to contribute significantly to their morbidity. although recent trials have demonstrated the efficacy of bisphosphonates in preventing skeletal complications in selected patients, t

CA 15-3 in patients with locoregional an

CA 15-3 in patients with locoregional and metastatic breast carcinoma

✍ J. G. Geraghty; E. C. Coveney; F. Sherry; N. J. O'Higgins; M. J. Dufy 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

Background. The value of circulating CA 15-3 levels was assessed in 129 patients with recurrent breast carcinoma. Methods. Patients were divided into four subgroups, according to the following: Group A, locoregional recurrence alone; Group B, locoregional and subsequent systemic recurrence; Group C

Aminoglutethimide in patients with metas

Aminoglutethimide in patients with metastatic breast cancer

✍ Takuma Nemoto; Dutzu Rosner; Jashbhai K. Patel; Thomas L. Dao 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

A comparative randomized trial of vinca

A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma

✍ Jonathan C. Yau; Ywee-Yong Yap; Aman U. Buzdar; Gabriel N. Hortobagyi; Gerald P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 2 views

Chemotherapy-induced neutropenia and fev

Chemotherapy-induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapy

✍ Zia Rahman; Laura Esparza-Guerra; Hwee-Yong Yap; Giuseppe Fraschini; Gerald Bode 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## METHODS. A total of 174 patients with previously treated metastatic breast carcinoma enrolled on 4 consecutive Phase II protocols were evaluated. Department of Breast Medical Oncology, Divi- ## RESULTS. Twenty-three percent of the patients had an episode of neutropenic sion of Medicine, The